CVR Medical Corp. (CRRVF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -0.02 USD | -952.94% |
| 2020 | -0.00 USD | 96.71% |
| 2019 | -0.05 USD | 48.4% |
| 2018 | -0.10 USD | 16.67% |
| 2017 | -0.12 CAD | -54.24% |
| 2016 | -0.08 CAD | 0.0% |
| 2015 | - USD | 100.0% |
| 2014 | -0.01 CAD | 1.82% |
| 2013 | -0.01 CAD | 71.5% |
| 2012 | -0.02 CAD | 24.31% |
| 2011 | -0.03 CAD | -355.36% |
| 2010 | -0.01 CAD | 76.67% |
| 2009 | -0.02 CAD | 95.56% |
| 2008 | -0.54 CAD | -390.91% |
| 2007 | -0.11 CAD | 38.89% |
| 2006 | -0.18 CAD | -38.46% |
| 2005 | -0.13 CAD | -67.74% |
| 2004 | -0.08 CAD | 61.25% |
| 2003 | -0.20 CAD | -100.0% |
| 2002 | -0.10 CAD | -148.14% |
| 2001 | -0.04 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q2 | -0.00 USD | -38.46% |
| 2022 Q4 | - USD | 100.0% |
| 2022 Q1 | -0.00 USD | 0.0% |
| 2022 Q3 | -0.00 USD | -33.33% |
| 2022 FY | - USD | 100.0% |
| 2021 Q2 | 0.00 USD | 145.45% |
| 2021 Q1 | -0.00 USD | 0.0% |
| 2021 Q3 | -0.00 USD | -260.0% |
| 2021 Q4 | - USD | 100.0% |
| 2021 FY | - USD | -952.94% |
| 2020 Q2 | -0.00 USD | 8.57% |
| 2020 Q3 | -0.00 USD | 3.13% |
| 2020 Q4 | - USD | 100.0% |
| 2020 FY | - USD | 96.71% |
| 2020 Q1 | -0.00 USD | 0.0% |
| 2019 FY | - USD | 48.4% |
| 2019 Q4 | - USD | 100.0% |
| 2019 Q3 | -0.00 USD | 83.44% |
| 2019 Q1 | -0.02 USD | 0.0% |
| 2019 Q2 | -0.02 USD | 23.47% |
| 2018 Q4 | - USD | 100.0% |
| 2018 Q3 | -0.02 CAD | 31.09% |
| 2018 Q2 | -0.02 CAD | -14.98% |
| 2018 Q1 | -0.02 CAD | 0.0% |
| 2018 FY | - USD | 16.67% |
| 2017 Q1 | -0.05 CAD | 0.0% |
| 2017 Q3 | -0.02 CAD | 40.56% |
| 2017 Q4 | - CAD | 100.0% |
| 2017 FY | - CAD | -54.24% |
| 2017 Q2 | -0.03 CAD | 45.83% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q3 | -0.00 CAD | -50.0% |
| 2015 Q4 | - USD | 100.0% |
| 2015 Q2 | -0.00 CAD | -9.09% |
| 2015 Q1 | -0.00 CAD | 0.0% |
| 2015 FY | - USD | 100.0% |
| 2014 Q2 | -0.00 CAD | -54.55% |
| 2014 Q3 | -0.00 CAD | 17.65% |
| 2014 Q4 | - CAD | 100.0% |
| 2014 FY | - CAD | 1.82% |
| 2014 Q1 | -0.00 CAD | 0.0% |
| 2013 Q2 | 0.00 CAD | 173.33% |
| 2013 FY | - CAD | 71.5% |
| 2013 Q4 | - CAD | 100.0% |
| 2013 Q3 | -0.00 CAD | -236.36% |
| 2013 Q1 | -0.00 CAD | 0.0% |
| 2012 FY | - CAD | 24.31% |
| 2012 Q3 | -0.01 CAD | 3.19% |
| 2012 Q4 | - CAD | 100.0% |
| 2012 Q1 | -0.01 CAD | 0.0% |
| 2012 Q2 | -0.01 CAD | -51.61% |
| 2011 Q1 | -0.01 CAD | 0.0% |
| 2011 Q2 | -0.00 CAD | 47.37% |
| 2011 Q3 | -0.01 CAD | -27.5% |
| 2011 FY | - CAD | -355.36% |
| 2011 Q4 | - CAD | 100.0% |
| 2010 Q4 | - CAD | 100.0% |
| 2010 Q3 | -0.01 CAD | 0.0% |
| 2010 FY | - CAD | 76.67% |
| 2010 Q2 | -0.01 CAD | 0.0% |
| 2009 FY | - CAD | 95.56% |
| 2008 Q3 | -0.59 CAD | -8839.39% |
| 2008 Q4 | - CAD | 100.0% |
| 2008 Q2 | -0.01 CAD | 24.14% |
| 2008 Q1 | -0.01 CAD | 0.0% |
| 2008 FY | - CAD | -390.91% |
| 2007 Q3 | -0.01 CAD | 73.99% |
| 2007 Q2 | -0.05 CAD | -304.31% |
| 2007 Q1 | -0.01 CAD | 0.0% |
| 2007 FY | - CAD | 38.89% |
| 2007 Q4 | - CAD | 100.0% |
| 2006 Q3 | -0.06 CAD | -229.55% |
| 2006 Q4 | - CAD | 100.0% |
| 2006 Q1 | -0.12 CAD | 0.0% |
| 2006 Q2 | -0.02 CAD | 85.33% |
| 2006 FY | - CAD | -38.46% |
| 2005 Q2 | -0.02 CAD | 36.16% |
| 2005 Q4 | - CAD | 100.0% |
| 2005 FY | - CAD | -67.74% |
| 2005 Q3 | -0.06 CAD | -226.01% |
| 2005 Q1 | -0.03 CAD | 0.0% |
| 2004 Q4 | - CAD | 100.0% |
| 2004 Q3 | -0.01 CAD | 6.67% |
| 2004 Q2 | -0.02 CAD | 37.24% |
| 2004 FY | - CAD | 61.25% |
| 2004 Q1 | -0.02 CAD | 0.0% |
| 2003 Q1 | -0.02 CAD | 0.0% |
| 2003 Q2 | -0.02 CAD | 19.61% |
| 2003 Q3 | -0.01 CAD | 14.02% |
| 2003 Q4 | - CAD | 100.0% |
| 2003 FY | - CAD | -100.0% |
| 2002 Q1 | -0.02 CAD | 0.0% |
| 2002 FY | - CAD | -148.14% |
| 2002 Q2 | -0.02 CAD | -18.01% |
| 2002 Q4 | - CAD | 100.0% |
| 2002 Q3 | -0.02 CAD | 1.05% |
| 2001 FY | - CAD | 0.0% |